The CXCR4/CXCL12 axis in cutaneous malignancies with an emphasis on melanoma

Histology and Histopathology

Volumn 29, Issue 12, 2014, Pages 1539-1546

  Mitchell, B ^a   Mahalingam, Meera ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

CXCL12; CXCR4; Melanoma

Indexed keywords

CHEMOKINE RECEPTOR CXCR4; CXCL12 PROTEIN, HUMAN; CXCR4 PROTEIN, HUMAN; STROMAL CELL DERIVED FACTOR 1;

DISEASE COURSE; HUMAN; MELANOMA; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SKIN TUMOR;

CHEMOKINE CXCL12; DISEASE PROGRESSION; HUMANS; MELANOMA; RECEPTORS, CXCR4; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 84912520494     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (54)

1. Alsayed Y., Ngo H., Runnels J., Leleu X., Singha U.K., Pitsillides C.M., Spencer J.A., Kimlinger T., Ghobrial J.M., Jia X., Lu G., Timm M., Kumar A., Cote D., Veilleux I., Hedin K.E., Roodman D.G., Witzig T.E., Kung A.L., Hideshima T., Anderson K.C., Lin C.P. and Ghobrial I. (2007). Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma. Blood 109, 2708-2717.
2. Balkwill F. (2004). Cancer and the chemokine network. Nat. Rev. Cancer 4, 540-550.
3. Bartolome R.A., Galvez B.G., Longo N., Baleux F., Muijen G.N.P. van, Sanchez-Mateos P., Arroyo A.G. and Teixido J. (2004). Stromal Cell-Derived Factor-1α Promotes Melanoma Cell Invasion across Basement Membranes Involving Stimulation of Membrane-Type 1 Matrix Metalloproteinase and Rho GTPase Activities. Cancer Res. 64, 2534-2543.
4. Bartolome R.A., Ferreiro S., Miquilena-Colina M.E., Martinez-Prats L., Soto-Montenegro M.L., Garcia-Bernal D., Vaquero J.J., Agami R., Delgado R., Desco M., Sanchez-Mateos P. and Teixido J. (2009). The chemokine receptor CXCR4 and the metalloproteinase MT1- MMP are mutually required during melanoma metastasis to lungs. Am. J. Pathol. 174, 602-612.
5. Basile J., Thiers B., Maize J. and Lathers D.M.R. (2008). Chemokine receptor expression in non-melanoma skin cancer. J. Cutan. Pathol. 35, 623-629.
6. Bollag W.B. and Hill W.D. (2013). CXCR4 in Epidermal Keratinocytes: Crosstalk within the Skin. J. Invest. Dermatol. 133, 2505-2508.
7. Bonig H. and Papayannopoulou T. (2013). Hematopoietic stem cell mobilization: updated conceptual renditions. Leukemia 27, 24-31.
8. Cesare S.D., Marshall J.C., Fernandes B.F., Logan P., Antecka E., Filho V.B. and Burnier M.N. (2007). In vitro characterization and inhibition of the CXCR4/CXCL12 chemokine axis in human uveal melanoma cell lines. Cancer Cell Int. 7, 17.
9. Clatot F., Picquenot J.M., Choussy O., Gouerant S., Moldovan C., Schultheis D., Cornic M., Francois A., Blot E. and Laberge-Le- Couteulx S. (2011). Intratumoural level of SDF-1 correlates with survival in head and neck squamous cell carcinoma. Oral Oncol. 47, 1062-1068.
10. Crump M.P., Gong J.H., Loetscher P., Rajarathnam K., Amara A., Arenzana-Seisdedos F., Virelizier J.L., Baggiolini M., Sykes B.D. and Clark-Lewis I. (1997). Solution structure and basis for functional activity of stromal cell-derived factor-1; dissociation of CXCR4 activation from binding and inhibition of HIV-1. EMBO J. 16, 6996- 7007.
11. Dobner B.C., Riechardt A.I., Joussen A.M., Englert S. and Bechrakis N.E. (2012). Expression of haematogenous and lymphogenous chemokine receptors and their ligands on uveal melanoma in association with liver metastasis. Acta Ophthalmol. (Copenh.) 90, e638-e644.
12. Domanska U.M., Kruizinga R.C., Nagengast W.B., Timmer-Bosscha H., Huls G., de Vries E.G.E. and Walenkamp A.M.E. (2013). A review on CXCR4/CXCL12 axis in oncology: No place to hide. Eur. J. Cancer 49, 219-230.
13. Drury L.J., Ziarek J.J., Gravel S., Veldkamp C.T., Takekoshi T., Hwang S.T., Heveker N., Volkman B.F. and Dwinell M.B. (2011). Monomeric and dimeric CXCL12 inhibit metastasis through distinct CXCR4 interactions and signaling pathways. Proc. Natl. Acad. Sci. USA 108, 17655-17660.
14. Franco R., Cantile M., Scala S., Catalano E., Cerrone M., Scognamiglio G., Pinto A., Chiofalo M.G., Caraco C., Anniciello A.M., Abbruzzese A., Caraglia M. and Botti G. (2010). Histomorphologic parameters and CXCR4 mRNA and protein expression in sentinel node melanoma metastasis are correlated to clinical outcome. Cancer Biol. Ther. 9, 423-429.
15. Fu X., Yang B., Lao S., Fan Y. and Wu C. (2013). Human memory-like NK cells migrating to tuberculous pleural fluid via IP-10/CXCR3 and SDF-1/CXCR4 axis produce IFN-γ in response to Bacille Calmette Guerin. Clin. Immunol. 148, 113-123.
16. Heinrich E.L., Lee W., Lu J., Lowy A.M. and Kim J. (2012). Chemokine CXCL12 activates dual CXCR4 and CXCR7-mediated signaling pathways in pancreatic cancer cells. J. Transl. Med. 10, 68.
17. Kim J., Mori T., Chen S.L., Amersi F.F., Martinez S.R., Kuo C., Turner R.R., Ye X., Bilchik A.J., Morton D.L. and Hoon D.S.B. (2006). Chemokine receptor CXCR4 expression in patients with melanoma and colorectal cancer liver metastases and the association with disease outcome. Ann. Surg. 244, 113-120.
18. Kim M., Koh Y.J., Kim K.E., Koh B.I., Nam D.H., Alitalo K., Kim I. and Koh G.Y. (2010). CXCR4 Signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche. Cancer Res. 70, 10411-10421.
19. Knapp C.F., Sayegh Z., Schell M.J., Rawal B., Ochoa T., Sondak V.K. and Messina J.L. (2012). Expression of CXCR4, E-cadherin, Bcl-2, and survivin in Merkel cell carcinoma: an immunohistochemical study using a tissue microarray. Am. J. Dermatopathol. 34, 592-596.
20. Kremer K.N., Clift I.C., Miamen A.G., Bamidele A.O., Qian N.X., Humphreys T.D. and Hedin K.E. (2011). Stromal cell-derived factor- 1 signaling via the CXCR4-TCR heterodimer requires phospholipase C-β3 and phospholipase C-γ1 for distinct cellular responses. J. Immunol. Baltim. Md 1950 187, 1440-1447.
21. Kuhnelt-Leddihn L., Muller H., Eisendle K., Zelger B. and Weinlich G. (2012). Overexpression of the chemokine receptors CXCR4, CCR7, CCR9, and CCR10 in human primary cutaneous melanoma: a potential prognostic value for CCR7 and CCR10? Arch. Dermatol. Res. 304, 185-193.
22. Liang Z., Zhan W., Zhu A., Yoon Y., Lin S., Sasaki M., Klapproth J.M.A., Yang H., Grossniklaus H.E., Xu J., Rojas M., Voll R.J., Goodman M.M., Arrendale R.F., Liu J., Yun C.C., Snyder J.P., Liotta D.C. and Shim H. (2012). Development of a unique small molecule modulator of CXCR4. PloS One 7, e34038.
23. Liu X., Liang F., Yang J., Li Z., Hou X., Wang Y. and Gao C. (2013). Effects of stromal cell derived factor-1 and CXCR4 on the promotion of neovascularization by hyperbaric oxygen treatment in skin flaps. Mol. Med. Rep. 8, 1118-1124.
24. Loetscher P., Moser B. and Baggiolini M. (2000). Chemokines and their receptors in lymphocyte traffic and HIV infection. Adv. Immunol. 74, 127-180.
25. Longo-Imedio M.I., Longo N., Trevino I., Lazaro P. and Sanchez-Mateos P. (2005). Clinical significance of CXCR3 and CXCR4 expression in primary melanoma. Int. J. Cancer 117, 861-865.
26. Luo D.H., Chen Q.Y., Liu H., Xu L.H., Zhang H.Z., Zhang L., Tang L.Q., Mo H.Y., Huang P.Y., Guo X. and Mai H.Q. (2013). The independent, unfavorable prognostic factors endothelin A receptor and chemokine receptor 4 have a close relationship in promoting the motility of nasopharyngeal carcinoma cells via the activation of AKT and MAPK pathways. J. Transl. Med. 11, 203.
27. Mithal D.S., Ren D. and Miller R.J. (2013). CXCR4 signaling regulates radial glial morphology and cell fate during embryonic spinal cord development. Glia 61, 1288-1305.
28. Mo W., Chen J., Patel A., Zhang L., Chau V., Li Y., Cho W., Lim K., Xu J., Lazar A.J., Creighton C.J., Bolshakov S., McKay R.M., Lev D., Le L.Q. and Parada L.F. (2013). CXCR4/CXCL12 mediate autocrine cell- cycle progression in NF1-associated malignant peripheral nerve sheath tumors. Cell 152, 1077-1090.
29. Monteagudo C., Ramos D., Pellin-Carcelen A., Gil R., Callaghan R.C., Martin J.M., Alonso V., Murgui A., Navarro L., Calabuig S., Lopez- Guerrero J.A., Jorda E. and Pellin A. (2012). CCL27-CCR10 and CXCL12-CXCR4 chemokine ligand-receptor mRNA expression ratio: new predictive factors of tumor progression in cutaneous malignant melanoma. Clin. Exp. Metastasis 29, 625-637.
30. Mori T., Kim J., Yamano T., Takeuchi H., Huang S., Umetani N., Koyanagi K. and Hoon D.S.B. (2005). Epigenetic up-regulation of CC chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. Cancer Res. 65, 1800-1807.
31. Muller A., Homey B., Soto H., Ge N., Catron D., Buchanan M.E., McClanahan T., Murphy E., Yuan W., Wagner S.N., Barrera J.L., Mohar A., Verastegui E. and Zlotnik A. (2001). Involvement of chemokine receptors in breast cancer metastasis. Nature 410, 50- 56.
32. Murakami T., Maki W., Cardones A.R., Fang H., Kyi A.T., Nestle F.O. and Hwang S.T. (2002). Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells. Cancer Res. 62, 7328-7334.
33. Nagasawa T., Hirota S., Tachibana K., Takakura N., Nishikawa S., Kitamura Y., Yoshida N., Kikutani H. and Kishimoto T. (1996). Defects of B-cell lymphopoiesis and bone-marrow myelopoiesis in mice lacking the CXC chemokine PBSF/SDF-1. 382, 635-638.
34. O'Boyle G., Swidenbank I., Marshall H., Barker C.E., Armstrong J., White S.A., Fricker S.P., Plummer R., Wright M. and Lovat P.E. (2013). Inhibition of CXCR4-CXCL12 chemotaxis in melanoma by AMD11070. Br. J. Cancer 108, 1634-1640.
35. Ou D.L., Chien H.F., Chen C.L., Lin T.C. and Lin L.I. (2008). Role of twist in head and neck carcinoma with lymph node metastasis. Anticancer Res. 28, 1355-1359.
36. Payne A.S. and Cornelius L.A. (2002). The role of chemokines in melanoma tumor growth and metastasis. J. Invest. Dermatol. 118, 915-922.
37. Robledo M.M., Bartolome R.A., Longo N., Rodríguez-Frade J.M., Mellado M., Longo I., Muijen G.N.P. van, Sanchez-Mateos P. and Teixido J. (2001). Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells. J. Biol. Chem. 276, 45098-45105.
38. Saini V., Staren D.M., Ziarek J.J., Nashaat Z.N., Campbell E.M., Volkman B.F., Marchese A. and Majetschak M. (2011). The CXC chemokine receptor 4 ligands ubiquitin and stromal cell-derived factor-1α function through distinct receptor interactions. J. Biol. Chem. 286, 33466-33477.
39. Scala S., Ottaiano A., Ascierto P.A., Cavalli M., Simeone E., Giuliano P., Napolitano M., Franco R., Botti G. and Castello G. (2005). Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin. Cancer Res. 11, 1835-1841.
40. Scala S., Giuliano P., Ascierto P.A., Ierano C., Franco R., Napolitano M., Ottaiano A., Lombardi M.L., Luongo M., Simeone E., Castiglia D., Mauro F., Michele I.D., Calemma R., Botti G., Caraco C., Nicoletti G., Satriano R.A. and Castello G. (2006). Human melanoma metastases express functional CXCR4. Clin. Cancer Res. 12, 2427-2433.
41. Scala S., Ierano C., Ottaiano A., Franco R., Mura A.L., Liguori G., Mascolo M., Staibano S., Ascierto P.A., Botti G., Rosa G.D. and Castello G. (2007). CXC chemokine receptor 4 is expressed in uveal malignant melanoma and correlates with the epithelioid-mixed cell type. Cancer Immunol. Immunother. 56, 1589-1595.
42. Sehgal A., Keener C., Boynton A.L., Warrick J., and Murphy G.P. (1998). CXCR-4, a chemokine receptor, is overexpressed in and required for proliferation of glioblastoma tumor cells. J. Surg. Oncol. 69, 99-104.
43. Shaked Y., Henke E., Roodhart J.M.L., Mancuso P., Langenberg M.H.G., Colleoni M., Daenen L.G., Man S., Xu P., Emmenegger U., Tang T., Zhu Z., Witte L., Streiter R.M., Bertolini F., Voest E.E., Benezra R. and Kerbel R.S. (2008). Rapid chemotherapy-induced acute endothelial progenitor cell mobilization: Implications for antiangiogenic drugs as chemosensitizing agents. Cancer Cell 14, 263-273.
44. Sierro F., Biben C., Martinez-Munoz L., Mellado M., Ransohoff R.M., Li M., Woehl B., Leung H., Groom J., Batten M., Harvey R.P., Martinez A.C., Mackay C.R. and Mackay F. (2007). Disrupted cardiac development but normal hematopoiesis in mice deficient in the second CXCL12/SDF-1 receptor, CXCR7. Proc. Natl. Acad. Sci. USA 104, 14759-14764.
45. Stein J.V. and Nombela-Arrieta C. (2005). Chemokine control of lymphocyte trafficking: a general overview. Immunology 116, 1-12.
46. Sun Y., Cheng Z., Ma L. and Pei G. (2002). β-Arrestin2 Is Critically Involved in CXCR4-mediated Chemotaxis, and This Is Mediated by Its Enhancement of p38 MAPK Activation. J. Biol. Chem. 277, 49212-49219.
47. Takabatake Y., Sugiyama T., Kohara H., Matsusaka T., Kurihara H., Koni P.A., Nagasawa Y., Hamano T., Matsui I., Kawada N., Imai E., Nagasawa T., Rakugi H. and Isaka Y. (2009). The CXCL12 (SDF- 1)/CXCR4 axis is essential for the development of renal vasculature. J. Am. Soc. Nephrol. 20, 1714-1723.
48. Toyozawa S., Yamamoto Y., Ishida Y., Kondo T., Nakamura Y. and Furukawa F. (2010). Immunohistochemical analysis of CXCR4 expression in fibrohistiocytic tumors. Acta Histochem. Cytochem. 43, 45-50.
49. Toyozawa S., Kaminaka C., Furukawa F., Nakamura Y., Matsunaka H. and Yamamoto Y. (2012). Chemokine receptor CXCR4 is a novel marker for the progression of cutaneous malignant melanomas. Acta Histochem. Cytochem. 45, 293-299.
50. Tucci M., Lucarini G., Giangiacomi M., Zizzi A., Criante P., Ricotti G. and Biagini G. (2006). Immunohistochemical study of apoptosis markers and involvement of chemokine CXCR4 in skin Merkel cell carcinoma. J. Eur. Acad. Dermatol. Venereol. 20, 1220-1225.
51. Tucci M., Lucarini G., Brancorsini D., Zizzi A., Pugnaloni A., Giacchetti A., Ricotti G. and Biagini G. (2007). Involvement of E-cadherin, betacatenin, Cdc42 and CXCR4 in the progression and prognosis of cutaneous melanoma. Br. J. Dermatol. 157, 1212-1216.
52. Uchida D., Begum N.M., Almofti A., Nakashiro K., Kawamata H., Tateishi Y., Hamakawa H., Yoshida H. and Sato M. (2003). Possible role of stromal-cell-derived factor-1/CXCR4 signaling on lymph node metastasis of oral squamous cell carcinoma. Exp. Cell Res. 290, 289-302.
53. Uchida D., Onoue T., Tomizuka Y., Begum N.M., Miwa Y., Yoshida H. and Sato M. (2007). Involvement of an autocrine stromal cell-derived factor-1/CXCR4 system on the distant metastasis of human oral squamous cell carcinoma. Mol. Cancer Res. 5, 685-694.
54. Uchida D., Onoue T., Kuribayashi N., Tomizuka Y., Tamatani T., Nagai H. and Miyamoto Y. (2011). Blockade of CXCR4 in oral squamous cell carcinoma inhibits lymph node metastases. Eur. J. Cancer 47, 452-459.